APA (7th ed.) Citation

Smith, L. R., Wloch, M. K., Ye, M., Reyes, L. R., Boutsaboualoy, S., Dunne, C. E., . . . Moss, R. B. (2010). Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin. Vaccine, 28(13), 2565-2572. https://doi.org/10.1016/j.vaccine.2010.01.029

Chicago Style (17th ed.) Citation

Smith, Larry R., et al. "Phase 1 Clinical Trials of the Safety and Immunogenicity of Adjuvanted Plasmid DNA Vaccines Encoding Influenza A Virus H5 Hemagglutinin." Vaccine 28, no. 13 (2010): 2565-2572. https://doi.org/10.1016/j.vaccine.2010.01.029.

MLA (9th ed.) Citation

Smith, Larry R., et al. "Phase 1 Clinical Trials of the Safety and Immunogenicity of Adjuvanted Plasmid DNA Vaccines Encoding Influenza A Virus H5 Hemagglutinin." Vaccine, vol. 28, no. 13, 2010, pp. 2565-2572, https://doi.org/10.1016/j.vaccine.2010.01.029.